Aegerion Pharmaceuticals, Inc. – Credit Agreements Watch

EX-10.3

from 8-K 12 pages Seventh Loan Modification Agreement

12/34/56

EX-10.3

from 425 12 pages Seventh Loan Modification Agreement

12/34/56

EX-10.2

from 8-K 48 pages Loan and Security Agreement

12/34/56

EX-10.2

from 425 48 pages Loan and Security Agreement

12/34/56

EX-10.3

from 10-Q 4 pages Sixth Loan Modification Agreement

12/34/56

EX-10.26

from 10-K/A 17 pages Fifth Loan Modification Agreement

12/34/56

EX-10.26

from 10-K 18 pages This Exhibit Has Been Redacted and Is the Subject of a Confidential Treatment Request. Redacted Material Is Marked With [*] and Has Been Filed Separately With the Securities and Exchange Commission. Fifth Loan Modification Agreement

12/34/56

EX-10.1

from 10-Q 3 pages Fourth Loan Modification Agreement

12/34/56

EX-10.24

from 10-K 6 pages Consent and Third Loan Modification Agreement

12/34/56

EX-10.23

from 10-K 3 pages Second Loan Modification Agreement

12/34/56

EX-10.2

from 10-Q 8 pages First Loan Modification Agreement

12/34/56

EX-10.1

from 8-K 30 pages Loan and Security Agreement

12/34/56

EX-10.1

from 8-K 50 pages Loan and Security Agreement

12/34/56

EX-10.9

from S-1/A 74 pages Loan and Security Agreement

12/34/56

EX-10.9

from S-1 72 pages Loan and Security Agreement

12/34/56

EX-10.18

from S-1 33 pages Loan and Security Agreement

12/34/56

EX-10.16

from S-1/A 33 pages Loan and Security Agreement

12/34/56